Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Links among paroxetine-induced sexual dysfunctions, gender, and CYP2D6 activity.

Journal of sex & marital therapy - 1 Jan 2000

Zourková Alexandra, Cesková Eva, Hadasová Eva, Ravcuková Barbara

Abstract excerpt

The aim of the study was to compare the distribution of therapeutic efficacy and sexual dysfunction during maintenance paroxetine treatment in 17 males and 38 females genotyped and phenotyped to determine their CYP2D6 metabolic status. Clinical results were monitored on scales Clinical Global Impression-Severity of Illness Scale (CGIS) and Arizona Sexual Experience Scale (ASEX). The phenotype procedure showed 7...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents, Second-Generation
Share to Cytochrome P-450 CYP2D6

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Czech Republic

Share to Depression

Share to Dose-Response Relationship, Drug

Share to Paroxetine

Share to Phenotype

Share to Treatment Outcome

Source

Identifiers

PMID: 17541852
DOI: 10.1080/00926230701385589

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Links among paroxetine-induced sexual dysfunctions, gender, and CYP2D6 activity.PMID 17541852Read ↗

Paroxetine-induced conversion of cytochrome P450 2D6 phenotype and occurence of adverse effects.Semantic proximity Read ↗

MDR1 in paroxetine-induced sexual dysfunction.Semantic proximity Read ↗

CYP2D6 and ABCB1 genetic variability: influence on paroxetine plasma level and therapeutic response.Semantic proximity Read ↗

Assessment of tramadol pharmacokinetics in correlation with CYP2D6 and clinical symptoms.Semantic proximity Read ↗

Paroxetine steady-state plasma concentration in relation to CYP2D6 genotype in extensive metabolizers.Semantic proximity Read ↗

Sexual dysfunction associated with major depressive disorder and antidepressant treatment.Semantic proximity Read ↗

Influence of sex and CYP2D6 genotype on mirtazapine disposition, evaluated in Spanish healthy volunteers.Semantic proximity Read ↗

Female sexual dysfunction in patients with major depressive disorder (MDD) treated with selective serotonin reuptake inhibitor (SSRI) and its association with serotonin 2A-1438 G/A single nucleotide polymorphisms.Semantic proximity Read ↗

CYP2D6 polymorphism in patients with eating disorders.Semantic proximity Read ↗

Cytochrome P450 2D6 genotype affects the pharmacokinetics of controlled-release paroxetine in healthy Chinese subjects: comparison of traditional phenotype and activity score systems.Semantic proximity Read ↗

Miotic action of tramadol is determined by CYP2D6 genotype.Semantic proximity Read ↗

Effects of CYP2D6 *10 and *41 Variants in Healthy Chinese Men on the Pharmacokinetics of Dapoxetine.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.